Add to Quick Collection All 4 Results
| Title | Author/Creator | Date | Full Text | Reviewed | |
|---|---|---|---|---|---|
| Measuring time to biochemical failure in the Trog 96.01 trial: when should the clock start ticking? | Denham, James W.; Steigler, Allison; Gleeson, Paul S.; D'Este, Catherine; Kumar, Mahesh... More | 2009 | — | ||
| Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer | Denham, James W.; Kumar, Mahesh; Turner, Sandra; Greer, Peter B.; D'Este, Catherine... More | 2009 | — | ||
| Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival? | Denham, James W.; Steigler, Allison; Wilcox, Chantelle; Lamb, David S.; Joseph, David... More | 2009 | — | ||
| Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial | Denham, James W.; Steigler, Allison; Gleeson, Paul S.; Greer, Peter B.; D'Este, Catherine... More | 2008 | — |